Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D00EYC
|
||||
| Former ID |
DIB009484
|
||||
| Drug Name |
F-7TG
|
||||
| Synonyms |
Recombinant human factor VIIa (hemophilia), GTC/LFB; RhFVIIa (hemophilia), GTC/LFB
|
||||
| Indication | Hemophilia [ICD9: 286; ICD10:D66-D68] | Phase 1 | [551675] | ||
| Company |
Catalyst biosciences; pfizer
|
||||
| Target and Pathway | |||||
| Target(s) | Coagulation factor VII | Target Info | Modulator | [543607] | |
| KEGG Pathway | Complement and coagulation cascades | ||||
| PANTHER Pathway | Angiogenesis | ||||
| Blood coagulation | |||||
| PathWhiz Pathway | Coagulation | ||||
| Reactome | BMAL1:CLOCK,NPAS2 activates circadian gene expression | ||||
| Extrinsic Pathway of Fibrin Clot Formation | |||||
| Gamma-carboxylation of protein precursors | |||||
| Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus | |||||
| Removal of aminoterminal propeptides from gamma-carboxylated proteins | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.